Colonic delivery of nicotine to treat inflammatory bowel disease

Details Colonic delivery of nicotine to treat inflammatory bowel disease Colonic delivery of nicotine to treat inflammatory bowel disease

1999-03-23

2000-12-26

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 902, A61K 932, A61K 31465

Patent

active

061660442

ABSTRACT:
A method is provided to treat inflammatory bowel disease by locally administering to the colon an effective amount of nicotine or a pharmaceutically acceptable salt thereof, preferably via formulations adapted for delayed oral release or rectal administration. Further provided is a novel formulation for the oral administration of nicotine comprising a polyacrylic polymer complexed with nicotine.

REFERENCES:
patent: 3877468 (1975-04-01), Lichtneckert et al.
patent: 3901248 (1975-08-01), Lichtneckert et al.
patent: 4855142 (1989-08-01), Fankhauser et al.
patent: 5069904 (1991-12-01), Masterson
patent: 5244668 (1993-09-01), Snipes
patent: 5362496 (1994-11-01), Baker et al.
patent: 5502080 (1996-03-01), Hitzig
patent: 5512306 (1996-04-01), Carlsson et al.
patent: 5549906 (1996-08-01), Santus
patent: 5593684 (1997-01-01), Baker et al.
patent: 5604231 (1997-02-01), Smith et al.
patent: 5662920 (1997-09-01), Santus
patent: 5721257 (1998-02-01), Baker et al.
patent: 5776957 (1998-07-01), Crooks et al.
patent: 5783207 (1998-07-01), Stanley et al.
patent: 5846983 (1998-12-01), Sandborn et al.
patent: 5889028 (1999-03-01), Sandborn et al.
patent: 5989535 (1999-11-01), Nayak
Srivastava, E. D., et al, Eur. J. Gastroenterol., 3, 815-818 (1991).
Thomas, G. A. O., et al, Eur. J. Gastroenterol., 8, 769-776 (1996).
Lichtiger, S., et al, N. Engl. J. Med. 330, No. 26, 1841-1845 (Jun. 30, 1994).
Sandborn, W. J., et al, Gastroenterology, 108, 1429-1435 (1994).
Thomas, G. A. O., et al, N. Engl. J. Med., 332, No. 15, 988-992 (Apr. 19, 1995).
Lichtiger, S., et al, Gastroenterology, vol. 104, No. 4, Part 2, p. A732 AGA Abstracts (Apr. 1993).
Pullan, R. D., et al, N. Engl. J. Med., 330, No. 12, 811-815 (Mar. 24, 1994).
Zins, B. J., J. Clin. Pharmacol., 37, 426-436 (1997).
Sandborn, W. J., et al., "Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis: A Randomized, Double-Blind Study, Placebo-Controlled Trial", presented at the annual meeting of the American Gastroenterology Association, May 20-22, 1996, San Francisco.
Sandborn, W. J., et al., Annals of Internal Medicine, vol. 126, No. 5, pp. 364-371 (Mar. 1997).
Cecil Textbook of Medicine, Wyngaarden, et al., eds., 19th edition, pp. 699-708, 1992, W. B. Saunders Company, Philadelphia.
Greenberg, G. R., et al., N. Eng. J. Med., vol. 331, No. 13, pp. 836-841 (Sep. 1994).
Anonymous, "Rectal Topical Corticosteroid Preparations", Drug and Therapeutics Bulletin 29, Publ. Consumer's Association, London, pp. 66-68 (1991).
Zins, B. J., et al., Gastroenterology, vol. 110, No. 4, p. A1054 (Apr. 1996).
Danish Budesonide Study Group, J. Gastroent., 1991, pp. 1225-1230.
Winder, T. A., et al., Scand. J. Gastroent. 28(8), pp. 701-704 (1993)--abstract only.
Handbook of Pharmaceutical Excipients, 2nd edition, p. 363.

Affiliated with

Also associated with

Rating

Colonic delivery of nicotine to treat inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Colonic delivery of nicotine to treat inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Colonic delivery of nicotine to treat inflammatory bowel disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-995263